Timothy E. Dribin

1 month ago | digitalcommons.library.tmc.edu | Douglas Mack |Timothy E. Dribin |Paul Turner |Richard Wasserman

BACKGROUND: Despite the promise of oral immunotherapy (OIT) to treat food allergies, this procedure is associated with potential risk. There is no current agreement about what elements should be included in the preparatory or consent process. OBJECTIVE: We developed consensus recommendations about the OIT process considerations and patient-specific factors that should be addressed before initiating OIT and developed a consensus OIT consent process and information form.